Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)

Thematic Poster
Chairs: D. Mannino (Lexington, United States of America), A. Johannessen (Bergen, Norway), E. Oelsner (New York, United States of America), E. Fuertes (London, United Kingdom)
Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting
H. Whittaker (London, United Kingdom), H. Mullerova (London, United Kingdom), D. Jarvis (London, United Kingdom), N. Barnes (London, United Kingdom), P. Jones (London, United Kingdom), C. Compton (London, United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
G. Brozek (Katowice, Poland), N. Nowak (Czosnow k Warszawy, Poland), J. Mateusz (Katowice, Poland), J. Zejda (Katowice, Poland)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Underweight and weight loss are assocaited with greater mortality from chronic obstructive pulmonary disease (COPD) in middle-aged Japanese: The JACC study
H. Wada (Tokyo, Japan), A. Ikeda (Tokyo, Japan), K. Maruyama (Tokyo, Japan), K. Yamagishi (Ibaraki, Japan), T. Tanigawa (Tokyo, Japan), A. Tamakoshi (HOkkaido, Japan), H. Iso (Osaka, Japan)
Congress or journal article abstract
Congress or journal article abstract
Eligibility for lung volume reduction surgery in COPD patients identified in a UK primary care setting
O. Connell (London, United Kingdom), H. Whittaker (London, United Kingdom), A. Elbehairy (London, United Kingdom), J. Campbell (London, United Kingdom), N. Hopkinson (London, United Kingdom), J. Quint (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
W. Meeraus (Uxbridge, United Kingdom), V. Benson (Uxbridge, United Kingdom), M. Tabberer (Uxbridge, United Kingdom), W. Fahy (Uxbridge, United Kingdom), H. Mullerova (Uxbridge, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinically relevant differences in COPD health status: systematic review and triangulation
H. Alma (Groningen, Netherlands), C. De Jong (Groningen, Netherlands), I. Tsiligianni (Heraklion, Crete, Greece), R. Sanderman (Groningen, Netherlands), J. Kocks (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Lower airway bacterial colonization patterns and species-specific interactions in COPD
D. Jacobs (Buffalo, United States of America), H. Ochs-Balcom (Buffalo, United States of America), J. Zhao (Buffalo, United States of America), T. Murphy (Buffalo, United States of America), S. Sethi (Buffalo, United States of America)
Congress or journal article abstract
Congress or journal article abstract
Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD
U. Nilsson (Umeå, Sweden), A. Blomberg (Umeå, Sweden), N. Mills (Edinburgh, United Kingdom), E. Rönmark (Umeå, Sweden), A. Lindberg (Umeå, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
W. Meeraus (Uxbridge, United Kingdom), H. Mullerova (Uxbridge, United Kingdom), M. Tabberer (Uxbridge, United Kingdom), W. Fahy (Uxbridge, United Kingdom), V. Benson (Uxbridge, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Blood eosinophils and obstructive lung disease in the general population
S. Wijnant (Ghent, Belgium), L. Lahousse (Ghent, Belgium), M. De Buyzere (Ghent, Belgium), G. Brusselle (Ghent, Belgium), E. Rietzschel (Ghent, Belgium)
Congress or journal article abstract
Congress or journal article abstract
Factors associated with airflow limitation in a population-based cohort of adults from the greater Copenhagen area
C. Bårnes (Copenhagen, Denmark), B. Thuesen (Copenhagen, Denmark), A. Linneberg (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark)
Congress or journal article abstract
Congress or journal article abstract
Sarcopenia in elderly population with chronic respiratory diseases: A population-based study
G. Benz I (Rotterdam, Netherlands), K. Trajanoska (Rotterdam, Netherlands), J. Schoufour (Rotterdam, Netherlands), L. Lahousse (Rotterdam, Netherlands), E. De Roos (Rotterdam, Netherlands), N. Terzikhan (Rotterdam, Netherlands), B. Striker (Rotterdam, Netherlands), O. Franco (Rotterdam, Netherlands), F. Rivadeneira (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands)
Congress or journal article abstract
Congress or journal article abstract
Incidence of asthma progression towards asthma-COPD overlap in old women
S. Chanoine (Grenoble, France), C. Marchal (Grenoble, France), S. Temam (Villejuif, France), O. Dumas (Villejuif, France), N. Le Moual (Villejuif, France), C. Pison (Grenoble, France), A. Fournier (Villejuif, France), G. Severi (Villejuif, France), M. Boutron-Ruault (Villejuif, France), R. Varraso (Villejuif, France), V. Siroux (Grenoble, France)
Congress or journal article abstract
Congress or journal article abstract
Description of the UK’s asthma and COPD inhaler use
C. Bloom (London, United Kingdom), I. Douglas (London, United Kingdom), L. Smeeth (London, United Kingdom), J. Quint (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Asthma-COPD overlap syndrome (ACOS) among subjects with newly diagnosed adult-onset asthma
M. Jaakkola (Oulu, Finland), Y. Wang (Oulu, Finland), T. Lajunen (Oulu, Finland), C. Lai (Taipei, Taiwan), J. Jaakkola (Oulu, Finland)
Congress or journal article abstract
Congress or journal article abstract
Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany)
Congress or journal article abstract
Congress or journal article abstract
Association between interpersonal and environmental factors and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD)
S. Moitra (Barcelona, Spain), M. Benet (Barcelona, Spain), A. Arbillaga-Etxarri (Barcelona, Spain), A. Marín (Badalona, Spain), A. Barberan-Garcia (Barcelona, Spain), E. Borrell (Badalona, Spain), D. Rodríguez (Barcelona, Spain), E. Gimeno-Santos (Barcelona, Spain), E. Balcells (Barcelona, Spain), M. Koreny (Barcelona, Spain), M. Monteagudo (Barcelona, Spain), P. Torán-Montserrat (Barcelona, Spain), P. Vall-Casas (Barcelona, Spain), R. Rodríguez-Roisin (Barcelona, Spain), J. Garcia-Aymerich (Barcelona, Spain)
Congress or journal article abstract
Congress or journal article abstract
C-reactive protein level and risk of developing COPD: The Kangbuk Samsung Cohort Study
S. Lim (Seoul, Republic of Korea), D. Zhao (Baltimore, United States of America), E. Guallar (Baltimore, United States of America), Y. Chang (Seoul, Republic of Korea), S. Ryu (Seoul, Republic of Korea), J. Shim (Seoul, Republic of Korea)
Congress or journal article abstract
Congress or journal article abstract
Magnitude and characteristics of COPD mortality in Kenya, 2012-2016
G. Kariuki (Nairobi, Kenya), G. Gathecha (Nairobi, Kenya)
Congress or journal article abstract
Congress or journal article abstract